Results Snapshot
Figures in Cr
Consolidated - Balance Sheet Results
Mar'25
Mar'24
Mar'23
Mar'22
Mar'21
Mar'20
EQUITY AND LIABILITIES
No of Months
12
12
12
12
12
12
Share Capital
6.31
6.31
6.31
6.31
6.31
6.31
Share Warrants & Outstandings
Total Reserve
4.11
8.89
11.20
17.70
17.61
17.16
Shareholder's Funds
10.42
15.20
17.51
24.01
23.92
23.47
Minority Interest
0.00
0.00
0.00
5.34
0.00
0.00
Long-Term Borrowings
54.13
48.89
53.43
33.52
27.84
13.65
Secured Loans
20.81
29.29
41.54
33.61
26.82
14.99
Unsecured Loans
33.31
19.60
11.88
-0.09
1.02
-1.33
Deferred Tax Assets / Liabilities
1.41
0.75
0.97
0.78
0.72
0.59
Other Long Term Liabilities
0
0
0
0
0
0
Long Term Trade Payables
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Non-Current Liabilities
55.53
49.64
48.03
34.30
28.56
14.24
Current Liabilities
Trade Payables
4.94
5.57
4.22
2.46
3.85
0.49
Other Current Liabilities
5.66
5.16
3.43
8.59
6.84
7.50
Short Term Borrowings
15.96
12.06
10.09
6.70
4.15
1.88
Short Term Provisions
0.00
0.00
0.00
0.00
0.00
0.00
Total Current Liabilities
26.56
22.79
17.75
17.76
14.84
9.87
Total Liabilities
85.88
85.40
84.71
81.40
69.63
48.57
ASSETS
Non-Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
Gross Block
74.87
68.70
64.37
41.16
33.11
0.00
Less: Accumulated Depreciation
19.37
14.54
7.14
5.04
3.72
0.00
Less : Impairment of Assets
0.00
0.00
0.00
0.00
0.00
0.00
Net Block
55.50
54.15
57.22
36.12
29.39
20.76
Lease Adjustment
0.00
0.00
0.00
0.00
0.00
0.00
Capital Work in Progress
0.00
0.00
0.00
22.78
19.34
7.00
Intangible assets under development
13.47
12.53
10.60
5.69
0.00
0.00
Pre-operative Expenses pending
0.00
0.00
0.00
0.00
0.00
0.00
Assets in transit
0.00
0.00
0.00
0.00
0.00
0.00
Non Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
Long Term Loans & Advances
0.00
0.00
0.00
0.00
0.00
0.00
Other Non Current Assets
1.56
1.55
1.64
2.32
0.97
0.97
Total Non-Current Assets
70.52
68.24
69.47
66.91
49.69
28.73
Current Assets Loans & Advances
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
6.51
7.52
7.16
7.24
9.76
14.01
Sundry Debtors
2.50
3.14
1.96
1.13
2.01
1.39
Cash and Bank
0.22
0.16
0.10
0.22
2.65
0.20
Other Current Assets
0.50
0.56
0.65
0.72
0.64
0.33
Short Term Loans and Advances
5.63
5.77
5.38
5.18
4.87
3.92
Total Current Assets
15.36
17.16
15.24
14.50
19.94
19.85
Net Current Assets (Including Current Investments)
-11.21
-5.62
-2.50
-3.26
5.09
9.97
Total Current Assets Excluding Current Investments
15.36
17.16
15.24
14.50
19.94
19.85
Miscellaneous Expenses not written off
0.00
0.00
0.00
0.00
0.00
0.00
Total Assets
85.88
85.40
84.71
81.40
69.63
48.57
Contingent Liabilities
0.00
0.00
0.00
16.19
1.01
0.00
Total Debt
70.08
60.95
50.80
40.22
31.99
17.37
Book Value per share (adjusted)
16.51
24.08
27.75
38.03
37.89
37.18
Balance Sheet Analysis Highlights
Borrowings
YoY Growth in year ended Mar 2025 is 14.98% vs 6.63% in Mar 2024
Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods;
Fixed Assets
YoY Growth in year ended Mar 2025 is 2.49% vs -5.37% in Mar 2024
Investments
No Investments in the last few periods;
Current Assets
YoY Growth in year ended Mar 2025 is -10.49% vs 12.60% in Mar 2024
Compare Balance Sheet Results of Vanta Bioscience
Figures in Cr
Consolidated - Balance Sheet Results
Change(INR)
Change(%)
No of Months
12
12
EQUITY AND LIABILITIES
Share Capital
6.31
0
6.31
0.00%
Share Warrants & Outstandings
Total Reserve
4.11
0
4.11
0.00%
Shareholder's Funds
10.42
0
10.42
0.00%
Minority Interest
0.00
0
0.00
0.00%
Long-Term Borrowings
54.13
0
54.13
0.00%
Secured Loans
20.81
0
20.81
0.00%
Unsecured Loans
33.31
0
33.31
0.00%
Deferred Tax Assets / Liabilities
1.41
0
1.41
0.00%
Other Long Term Liabilities
0.00
0
0.00
0.00%
Long Term Trade Payables
0.00
0
0.00
0.00%
Long Term Provisions
0.00
0
0.00
0.00%
Total Non-Current Liabilities
55.53
0
55.53
0.00%
Current Liabilities
Trade Payables
4.94
0
4.94
0.00%
Other Current Liabilities
5.66
0
5.66
0.00%
Short Term Borrowings
15.96
0
15.96
0.00%
Short Term Provisions
0.00
0
0.00
0.00%
Total Current Liabilities
26.56
0
26.56
0.00%
Total Liabilities
85.88
0
85.88
0.00%
ASSETS
Non-Current Assets
0.00
0
0.00
0.00%
Gross Block
74.87
0
74.87
0.00%
Less: Accumulated Depreciation
19.37
0
19.37
0.00%
Less : Impairment of Assets
0.00
0
0.00
0.00%
Net Block
55.50
0
55.50
0.00%
Lease Adjustment
0.00
0
0.00
0.00%
Capital Work in Progress
0.00
0
0.00
0.00%
Intangible assets under development
13.47
0
13.47
0.00%
Pre-operative Expenses pending
0.00
0
0.00
0.00%
Assets in transit
0.00
0
0.00
0.00%
Non Current Investments
0.00
0
0.00
0.00%
Long Term Loans & Advances
0.00
0
0.00
0.00%
Other Non Current Assets
1.56
0
1.56
0.00%
Total Non-Current Assets
70.52
0
70.52
0.00%
Current Assets Loans & Advances
Current Investments
0.00
0
0.00
0.00%
Inventories
6.51
0
6.51
0.00%
Sundry Debtors
2.50
0
2.50
0.00%
Cash and Bank
0.22
0
0.22
0.00%
Other Current Assets
0.50
0
0.50
0.00%
Short Term Loans and Advances
5.63
0
5.63
0.00%
Total Current Assets
15.36
0
15.36
0.00%
Net Current Assets (Including Current Investments)
-11.21
0
-11.21
0.00%
Total Current Assets Excluding Current Investments
15.36
0
15.36
0.00%
Miscellaneous Expenses not written off
0.00
0
0.00
0.00%
Total Assets
85.88
0
85.88
0.00%
Contingent Liabilities
0.00
0
0.00
0.00%
Total Debt
70.08
0
70.08
0.00%
Book Value per share (adjusted)
16.51
0
16.51
0.00%
Annual - Borrowings
Borrowings 70.08 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 14.98% vs 6.63% in Mar 2024
Annual - Other Long Term Liabilities
No Other Long Term Liabilities in the last few periods
No Other Long Term Liabilities in the last few periods;
Annual - Fixed Assets
Fixed Assets 55.50 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is 2.49% vs -5.37% in Mar 2024
Annual - Investments
No Investments in the last few periods
No Investments in the last few periods;
Annual - Current Assets
Current Assets 15.36 Cr
in Mar 2025Figures in Cr
YoY Growth in year ended Mar 2025 is -10.49% vs 12.60% in Mar 2024






